E-cadherin expression remained at a significantly higher level in the SG-/- primary tumour tissue as compared with SG+/- primary tumour tissue (Fig 4A and 4B), indicating a less invasive phenotype of serglycin-deficient tumour cells. The gene discussed is CDH1; the disease is neoplasm.